Biomedical Company Announces Patent Issued For Malaria Treatment
Ocean Biomedical's Breakthrough in Malaria Treatment: A Deep Dive into the PfGARP Patent.
Malaria continues to be a formidable global health challenge, particularly in regions with limited access to effective healthcare. Recent developments in the fight against this disease have brought hope. Ocean Biomedical, Inc., a biopharmaceutical company headquartered in Providence, Rhode Island, has announced a significant advancement in malaria treatment through the issuance of a U.S. patent for PfGARP malaria antibodies. This patent is a testament to the innovative research led by Dr. Jonathan Kurtis, co-founder of Ocean Biomedical. It represents a potential turning point in malaria prevention and treatment. $JBDI Holdings (JBDI.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
